J C States - JoVE Visualize

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

Molecular Pharmacology|January 1, 1996

Mitogenic effects of tetrahydrobiopterin in PC12 cellsP Z Anastasiadis, J C States, B A Imerman, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987

Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicingA L Akeson, D A Wiginton, J C States, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000

Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phaseM J McCabe, K P Singh, S A Reddy, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1987

Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiencyM L Markert, M S Hershfield, D A Wiginton, et al.

Biochemistry|December 16, 1986

Complete sequence and structure of the gene for human adenosine deaminaseD A Wiginton, D J Kaplan, J C States, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 21, 2009

Role of human CYP1A1 and NAT2 in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutagenicity and DNA adductsJ Bendaly, K J Metry, M A Doll, et al.

Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

Molecular Pharmacology|January 1, 1996

Mitogenic effects of tetrahydrobiopterin in PC12 cellsP Z Anastasiadis, J C States, B A Imerman, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987

Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicingA L Akeson, D A Wiginton, J C States, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000

Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phaseM J McCabe, K P Singh, S A Reddy, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1987

Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiencyM L Markert, M S Hershfield, D A Wiginton, et al.

Biochemistry|December 16, 1986

Complete sequence and structure of the gene for human adenosine deaminaseD A Wiginton, D J Kaplan, J C States, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 21, 2009

Role of human CYP1A1 and NAT2 in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutagenicity and DNA adductsJ Bendaly, K J Metry, M A Doll, et al.

Pageof 4